Who is sponsoring NCT05383846?

NCT05383846 is sponsored by University of Nottingham.

What drugs are being tested in NCT05383846?

Interventions in NCT05383846: Experimental Narrative Exposure Therapy.

What condition does NCT05383846 study?

NCT05383846 studies Traumatic Stress Disorder.

Is NCT05383846 still recruiting?

NCT05383846 is currently completed. Last updated 24 August 2023.

Last reviewed 2023-08-24 · How we verify

NCT05383846

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Exposing Narrative Exposure Therapy

Completed NA Last updated 24 August 2023

What this trial tests

NA trial testing Experimental Narrative Exposure Therapy in Traumatic Stress Disorder in 4 participants. Completed in 30 October 2022.

Timeline

14 January 2022

Primary endpoint
30 October 2022

30 October 2022

Quick facts

Lead sponsor	University of Nottingham
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	sequential
Masking	none
Primary purpose	other
Enrollment	4
Start date	14 January 2022
Primary completion	30 October 2022
Estimated completion	30 October 2022
Sites	1 location across United Kingdom

Drugs / interventions tested

Experimental Narrative Exposure Therapy

Conditions studied

Traumatic Stress Disorder — all drugs for Traumatic Stress Disorder →

Sponsor

University of Nottingham

Who can join

18 and older, any sex, with Traumatic Stress Disorder. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The main purpose of the study is to further develop an existing measure of autobiographical memory integration (ABMI) to investigate and clarify the ABMI change process specific to narrative exposure therapy (NET).

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Traumatic Stress Disorder

Currently open trials in the same condition.

NCT06419387 — The Effect of Flash Technique Via Self-Therapy App on Depression, Anxiety, and Traumatic Symptoms · NA · active not recruiting

Other University of Nottingham trials

Trials by the same sponsor.

NCT07518381 — Medication Understanding in MS · not yet recruiting
NCT07355556 — Technology Supported Improvement, Management and Prevention of Accidental Falls in Hospitals · not yet recruiting
NCT07506408 — Randomised Study of Web-Based Auditory Training With Varying Perceptual and Cognitive Demands on Training Gains and Gene · NA · recruiting
NCT07237529 — What is the Feasibility of Narrative Exposure Therapy (NET) for People Experiencing Psychosis? · NA · not yet recruiting
NCT07237997 — Protein Supplementation During Dialysis (PROSED) · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05383846 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Nottingham
Last refreshed: 24 August 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05383846.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing